AKCEA-APO(a)-LRx (ISIS 681257)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AKCEA-APO(a)-LRx (ISIS 681257), covering 2020-10-30 to 2020-10-30. Get the full timeline:
Most recent: Clinical Trial Update: Phase 2 Study of ISIS 681257 (AKCEA-APO(a)-LRx) in Participants With Hyperlipoproteinemia(a) and Cardiovascular Disease [Phase 2]